Showing 791-800 of 987 results for "".
- 2025 AAD: New Technologies for Face and Body Treatmentshttps://modernaesthetics.com/news/2025-aad-new-technologies-for-face-and-body-treatments-1/2473754/Skin tightening, innovations for cellulite and contouring, muscle stimulation methods, and hair restoration technology were the topics of “New Technologies for the Face and Body” presented by Neil Sadick, MD, FACP, FAACS, FACPh, FAAD, during the “Future of Cosmetic Dermatology” session at the 202
- Research Letter: Molecule Enhances Skin Barrier, Reduces Retinoid Side Effectshttps://modernaesthetics.com/news/research-letter-molecule-enhances-skin-barrier-reduces-retinoid-side-effects/2473752/A formulation containing Epicutis Skincare’s proprietary TSC molecule significantly reduced erythema and dryness caused by tretinoin, according to a research letter published in the Journal of Cosmetic Dermatology. The
- Closing the Healthcare Gender Gap as a Key to Optimize Female Longevityhttps://modernaesthetics.com/news/closing-the-healthcare-gender-gap-as-a-key-to-optimize-female-longevity/2473748/"The story of women's struggle for equality belongs to no single feminist nor to any one organization but to the collective efforts of all who care about human rights." —Gloria Steinem The United Nations has declared the theme for this year’s International
- Skinbetter Science Launches BioRewind Skin Health Dietary Supplement to Combat Skin Glycationhttps://modernaesthetics.com/news/skinbetter-science-launches-biorewind-skin-health-dietary-supplement-to-combat-skin-glycation/2473747/Skinbetter science launched BioRewind, a skin health dietary supplement with a purpose of visibly improving skin quality by helping reduce advanced glycation endproducts (AGEs), on Monday. Glycation is a key contributor to skin aging and this supplement’s formula is clinically demonstrate
- LaserAway, Rejuran Partner to Bring Leading South Korea Skin Booster to UShttps://modernaesthetics.com/news/laseraway-rejuran-partner-to-bring-south-koreas-no-1-skin-booster-to-us-1/2473746/A leading South Korean salmon DNA-based treatment will soon be available in the US under a new partnership announced by Rejuran. LaserAway, an aesthetic practice with more than 175 locations across the country, will help drive Rejuran’s first major US market entry, according to a
- Aesthetic Treatments Becoming More Popular Among Men, AAFPRS Data Showshttps://modernaesthetics.com/news/aesthetic-treatments-becoming-more-popular-among-men-aafprs-data-shows/2473744/While most patients for aesthetic treatments and procedures are women, men are beginning to embrace the industry, according to new data from the American Academy of Facial Plastic and Reconstructive Surgery. Men continue to surpass women when it comes to hair transplantation. Among AAFPRS
- California Lawmaker Introduces Legislation to Stop Sale of ‘Anti-Aging’ Skincare Products to Childrenhttps://modernaesthetics.com/news/california-lawmaker-introduces-legislation-to-stop-sale-of-anti-aging-skincare-products-to-children/2473742/A California lawmaker aims to protect children from anti-aging products as a result of the “Sephora kids” trend. The “Sephora kids” trend came about with the social media influencer boom, when skincare companies used influencers to market their products; but they also receive unexpected consumers
- FDA Approves New HA Gels From Evolushttps://modernaesthetics.com/news/fda-approves-new-ha-gels-from-evolus/2473740/The US Food and Drug Administration has approved Evolysse™ Form and Evolysse™ Smooth injectable hyaluronic acid (HA) gels, the first two products in the Evolysse™ collection, Evolus announced. These approvals mark Evolus’ entry into the United States HA dermal filler market and solidifies the com
- AMI Opens Three New US Training Centershttps://modernaesthetics.com/news/ami-opens-three-new-us-training-centers/2473739/Allergan Medical Institute (AMI) will open three new state-of-the-art training centers in the United States, according to an announcement from Allergan Aesthetics, an AbbVie company. AMI says its curriculum is designed to accelerate the science and art of aesthetics and, along with the com
- Galderma Seeks to Address Facial Volume Loss From GLP-1 Medications with Injectable Portfoliohttps://modernaesthetics.com/news/new-datas-promising-results-to-predominant-aesthetic-concerns-for-prescription-weight-loss-medications/2473730/Galderma announced positive first results last week from a trial designed to explore the benefits of Restylane Lyft or Contour in combination with Sculptra in patients with medication-driven weight loss with associated facial volume loss. According to a press release from the manufacturer,